138 related articles for article (PubMed ID: 15182179)
21. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
22. L-alanine-glyoxylate aminotransferase II of rat kidney and liver mitochondria possesses cysteine S-conjugate beta-lyase activity: a contributing factor to the nephrotoxicity/hepatotoxicity of halogenated alkenes?
Cooper AJ; Krasnikov BF; Okuno E; Jeitner TM
Biochem J; 2003 Nov; 376(Pt 1):169-78. PubMed ID: 12859250
[TBL] [Abstract][Full Text] [Related]
23. Requirement for the two AhpF cystine disulfide centers in catalysis of peroxide reduction by alkyl hydroperoxide reductase.
Li Calzi M; Poole LB
Biochemistry; 1997 Oct; 36(43):13357-64. PubMed ID: 9341228
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome b5 reductase: role of the si-face residues, proline 92 and tyrosine 93, in structure and catalysis.
Marohnic CC; Crowley LJ; Davis CA; Smith ET; Barber MJ
Biochemistry; 2005 Feb; 44(7):2449-61. PubMed ID: 15709757
[TBL] [Abstract][Full Text] [Related]
25. The functional role of cysteines in isopenicillin N synthase. Correlation of cysteine reactivities toward sulfhydryl reagents with kinetic properties of cysteine mutants.
Kriauciunas A; Frolik CA; Hassell TC; Skatrud PL; Johnson MG; Holbrook NL; Chen VJ
J Biol Chem; 1991 Jun; 266(18):11779-88. PubMed ID: 2050677
[TBL] [Abstract][Full Text] [Related]
26. Substitution of cysteine for a conserved alanine residue in the catalytic center of type II iodothyronine deiodinase alters interaction with reducing cofactor.
Kuiper GG; Klootwijk W; Visser TJ
Endocrinology; 2002 Apr; 143(4):1190-8. PubMed ID: 11897672
[TBL] [Abstract][Full Text] [Related]
27. Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase.
Tiedge M; Richter T; Lenzen S
Arch Biochem Biophys; 2000 Mar; 375(2):251-60. PubMed ID: 10700381
[TBL] [Abstract][Full Text] [Related]
28. Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction.
Sohn J; Rudolph J
Biochemistry; 2003 Sep; 42(34):10060-70. PubMed ID: 12939134
[TBL] [Abstract][Full Text] [Related]
29. Redox regulation of SH2-domain-containing protein tyrosine phosphatases by two backdoor cysteines.
Chen CY; Willard D; Rudolph J
Biochemistry; 2009 Feb; 48(6):1399-409. PubMed ID: 19166311
[TBL] [Abstract][Full Text] [Related]
30. Regulation of PTP1B via glutathionylation of the active site cysteine 215.
Barrett WC; DeGnore JP; König S; Fales HM; Keng YF; Zhang ZY; Yim MB; Chock PB
Biochemistry; 1999 May; 38(20):6699-705. PubMed ID: 10350489
[TBL] [Abstract][Full Text] [Related]
31. Essential cysteines in 3-deoxy-D-manno-octulosonic acid 8-phosphate synthase from Escherichia coli: analysis by chemical modification and site-directed mutagenesis.
Salleh HM; Patel MA; Woodard RW
Biochemistry; 1996 Jul; 35(27):8942-7. PubMed ID: 8688430
[TBL] [Abstract][Full Text] [Related]
32. Effects of biological oxidants on the catalytic activity and structure of group VIA phospholipase A2.
Song H; Bao S; Ramanadham S; Turk J
Biochemistry; 2006 May; 45(20):6392-406. PubMed ID: 16700550
[TBL] [Abstract][Full Text] [Related]
33. Mutational analysis of the three cysteines and active-site aspartic acid 103 of ketosteroid isomerase from Pseudomonas putida biotype B.
Kim SW; Joo S; Choi G; Cho HS; Oh BH; Choi KY
J Bacteriol; 1997 Dec; 179(24):7742-7. PubMed ID: 9401033
[TBL] [Abstract][Full Text] [Related]
34. Thiol modification and site directed mutagenesis of the flavin domain of spinach NADH:nitrate reductase.
Trimboli AJ; Quinn GB; Smith ET; Barber MJ
Arch Biochem Biophys; 1996 Jul; 331(1):117-26. PubMed ID: 8660690
[TBL] [Abstract][Full Text] [Related]
35. Structure-function roles of four cysteine residues in the human arsenic (+3 oxidation state) methyltransferase (hAS3MT) by site-directed mutagenesis.
Song X; Geng Z; Zhu J; Li C; Hu X; Bian N; Zhang X; Wang Z
Chem Biol Interact; 2009 May; 179(2-3):321-8. PubMed ID: 19167370
[TBL] [Abstract][Full Text] [Related]
36. The CXXC motif at the N terminus of an alpha-helical peptide.
Iqbalsyah TM; Moutevelis E; Warwicker J; Errington N; Doig AJ
Protein Sci; 2006 Aug; 15(8):1945-50. PubMed ID: 16877711
[TBL] [Abstract][Full Text] [Related]
37. Control of oxidation-reduction potentials in flavodoxin from Clostridium beijerinckii: the role of conformation changes.
Ludwig ML; Pattridge KA; Metzger AL; Dixon MM; Eren M; Feng Y; Swenson RP
Biochemistry; 1997 Feb; 36(6):1259-80. PubMed ID: 9063874
[TBL] [Abstract][Full Text] [Related]
38. The strength of dehalogenase-substrate hydrogen bonding correlates with the rate of Meisenheimer intermediate formation.
Dong J; Lu X; Wei Y; Luo L; Dunaway-Mariano D; Carey PR
Biochemistry; 2003 Aug; 42(31):9482-90. PubMed ID: 12899635
[TBL] [Abstract][Full Text] [Related]
39. Reactions of human liver peroxisomal alanine:glyoxylate aminotransferase with beta-chloro-L-alanine and L-cysteine: spectroscopic and kinetic analysis.
Bertoldi M; Cellini B; Paiardini A; Montioli R; Borri Voltattorni C
Biochim Biophys Acta; 2008 Sep; 1784(9):1356-62. PubMed ID: 18492492
[TBL] [Abstract][Full Text] [Related]
40. Effects of the E177K mutation in D-amino acid transaminase. Studies on an essential coenzyme anchoring group that contributes to stereochemical fidelity.
van Ophem PW; Peisach D; Erickson SD; Soda K; Ringe D; Manning JM
Biochemistry; 1999 Jan; 38(4):1323-31. PubMed ID: 9930994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]